
Scar Treatment Market Report and Forecast 2025-2034
Description
The scar treatment market size was valued at USD 22.56 Billion in 2024, driven by the rising prevalence of demand for cosmetic procedures across the 8 major markets. The market is expected to grow at a CAGR of 11.00% during the forecast period of 2025-2034, to reach USD 64.06 Billion by 2034.
Scar Treatment Market Overview
Scar treatment includes a range of techniques and products used to reduce, mask, or completely remove scars on the skin. Scars may be caused by injuries, surgeries, burns, acne, and other skin disorders. It develops as a result of the body's natural healing process. Topical creams, gels, silicone sheets, laser therapy, surgery, and injections are amongst the common treatments for treating scars.
The scar treatment market growth is driven by individuals becoming more self-conscious about their appearance. This has resulted in increased scar removal and reduction treatments. Consequently, resulting in increased incidence in approvals from regulatory authorities. For instance, in August 2023, FDA approved Sofwave Medical Ltd.'s Precise SUPERB Applicator to treat acne scars, expanding its list of approved uses beyond cellulite. After three sessions, a multicenter clinical research spread across multiple US locations showed a notable improvement in the appearance of acne scars. Most patients expressed relief and great pleasure with their outcomes. There were no significant adverse events in the research, which showed a positive safety profile.
To meet the rising scar treatment market demand, mergers and collaborations are witnessing a significant surge. In June 2023, International Medical Lasers (IML) partnered with DEKA Trio to offer laser accessories, including a scanner for CO2 laser-assisted scar reconstruction. The terms of agreement also focused on an FDA approved novel scanner for surgical scar correction By collaborating with global medical providers and manufacturers, new-age and technology driven companies are bringing cutting-edge medical technology to the markets, further driving its growth.
The scar treatment market share for products and services continues to expand, driven by rising application in the realm of medical aesthetics for non-surgical alternatives. People are looking for less intrusive ways to repair scars and rejuvenate their skin instead of undergoing typical surgical procedures. As laser-based procedures for skin rejuvenation and scar correction become more common, there is an increasing demand for cutting-edge instruments and technology that can produce good outcomes with little risk or downtime.
Scar Treatment Market Trends
Scar Treatment Market Segmentation
Market Breakup by Scar Type
Market Breakup by Product Creams
Gels
Silicon Sheets
Others CO2 Laser
Pulse-dyed Laser
Others
Market Breakup by End User
Market Breakup by Region Germany
France
Italy
Spain
United Kingdom
Scar Treatment Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Key Highlights of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment: Financial Analysis
Product Portfolio
Demographic Reach and Achievements
Mergers and Acquisitions
Certifications
Scar Treatment Market Overview
Scar treatment includes a range of techniques and products used to reduce, mask, or completely remove scars on the skin. Scars may be caused by injuries, surgeries, burns, acne, and other skin disorders. It develops as a result of the body's natural healing process. Topical creams, gels, silicone sheets, laser therapy, surgery, and injections are amongst the common treatments for treating scars.
The scar treatment market growth is driven by individuals becoming more self-conscious about their appearance. This has resulted in increased scar removal and reduction treatments. Consequently, resulting in increased incidence in approvals from regulatory authorities. For instance, in August 2023, FDA approved Sofwave Medical Ltd.'s Precise SUPERB Applicator to treat acne scars, expanding its list of approved uses beyond cellulite. After three sessions, a multicenter clinical research spread across multiple US locations showed a notable improvement in the appearance of acne scars. Most patients expressed relief and great pleasure with their outcomes. There were no significant adverse events in the research, which showed a positive safety profile.
To meet the rising scar treatment market demand, mergers and collaborations are witnessing a significant surge. In June 2023, International Medical Lasers (IML) partnered with DEKA Trio to offer laser accessories, including a scanner for CO2 laser-assisted scar reconstruction. The terms of agreement also focused on an FDA approved novel scanner for surgical scar correction By collaborating with global medical providers and manufacturers, new-age and technology driven companies are bringing cutting-edge medical technology to the markets, further driving its growth.
The scar treatment market share for products and services continues to expand, driven by rising application in the realm of medical aesthetics for non-surgical alternatives. People are looking for less intrusive ways to repair scars and rejuvenate their skin instead of undergoing typical surgical procedures. As laser-based procedures for skin rejuvenation and scar correction become more common, there is an increasing demand for cutting-edge instruments and technology that can produce good outcomes with little risk or downtime.
Scar Treatment Market Trends
Scar Treatment Market Segmentation
Market Breakup by Scar Type
- Atrophic Scars
- Hypertrophic and Keloid Scars
- Contracture Scars
- Stretch Marks
Market Breakup by Product
- Topical Products
- Laser Products
- Injectable
- Others
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centers
- Others
Market Breakup by Region
- United States
- EU-4 and the United Kingdom
- Japan
- India
Scar Treatment Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Alliance Pharma PLC
- Perrigo Company plc
- Newmedical Technology Inc.
- Sonoma Pharmaceuticals, Inc.
- HRA Pharma
- Boston Scientific Corporation
- CCA Industries, Inc.
- Avita Medical,Inc.
- Smith & Nephew PLC
- Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
- Sientra, Inc.
- Mölnlycke Health Care AB
- Merz Pharma
- POLYTECH Health & Aesthetics GmbH
- CYNOSURE LUTRONIC
Key Highlights of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
- Scar Type
- Product
- End User
- Region
- Atrophic Scars
- Hypertrophic and Keloid Scars
- Contracture Scars
- Stretch Marks
- Topical Products
- Laser Products
- Injectable
- Others
- Hospitals
- Ambulatory Surgical Centers
- Others
- United States
- EU-4 and the United Kingdom
- Japan
- India
- Market Drivers and Constraints
- SWOT Analysis
- Porter’s Five Forces Model
- Key Demand Indicators
- Key Price Indicators
- Industry Events, Initiatives, and Trends
- Value Chain Analysis
- Market Structure
- Company Profiles
- Alliance Pharma PLC
- Perrigo Company plc
- Newmedical Technology Inc.
- Sonoma Pharmaceuticals, Inc.
- HRA Pharma
- Boston Scientific Corporation
- CCA Industries, Inc.
- Avita Medical,Inc.
- Smith & Nephew PLC
- Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
- Sientra, Inc.
- Mölnlycke Health Care AB
- Merz Pharma
- POLYTECH Health & Aesthetics GmbH
- CYNOSURE LUTRONIC
- How is the market landscape expected to evolve in the forecast period?
- What future trends can be anticipated in the market?
- What will be the effect of each driver, challenge, and opportunity on the market?
- Which regional market is expected to experience expedited growth during the forecast period?
- Which production type will lead the market growth?
- Which end user is expected to dominate the respective market segment?
- What are the key research initiatives expected to boost the market value during the forecast period?
- Which treatment type is poised to make the highest impact on the Scar treatment market growth?
- What are the market shares, strategies, and product portfolios of the leading players in the market?
- How is the regulatory landscape shaping the market?
- What are the market dynamics, trends, and growth prospects in the key regional markets?
- How is technology innovation impacting the development of scar treatment?
- What are the investment opportunities and potential risks associated with the market?
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Scar Treatment Market Overview – 8 Major Markets
- 3.1 Scar Treatment Market Historical Value (2018-2024)
- 3.2 Scar Treatment Market Forecast Value (2025-2034)
- 4 Scar Overview
- 4.1 Guidelines and Stages
- 4.2 Pathophysiology
- 4.3 Screening and Diagnosis
- 4.4 Scar Pathway
- 5 Patient Profile
- 5.1 Patient Profile Overview
- 5.2 Patient Psychology and Emotional Impact Factors
- 5.3 Risk Assessment and Scar Type Success Rate
- 6 Scar Epidemiology Scenario and Forecast – 8 Major Markets
- 6.1 8MM Epidemiology Scenario Overview (2018-2034)
- 6.2 United States Scar Epidemiology Scenario and Forecast (2018-2034)
- 6.3 EU-4 and United Kingdom Scar Epidemiology Scenario and Forecast (2018-2034)
- 6.3.1 Germany Scar Epidemiology Scenario and Forecast (2018-2034)
- 6.3.2 France Scar Epidemiology Scenario and Forecast (2018-2034)
- 6.3.3 Italy Scar Epidemiology Scenario and Forecast (2018-2034)
- 6.3.4 Spain Scar Epidemiology Scenario and Forecast (2018-2034)
- 6.3.5 United Kingdom Scar Epidemiology Scenario and Forecast (2018-2034)
- 6.4 Japan Scar Epidemiology Scenario and Forecast (2018-2034)
- 6.5 India Scar Epidemiology Scenario and Forecast (2018-2034)
- 7 Scar Treatment Market Landscape – 8 Major Markets
- 7.1 Scar Treatment: Developers Landscape
- 7.1.1 Analysis by Year of Establishment
- 7.1.2 Analysis by Company Size
- 7.1.3 Analysis by Region
- 7.2 Scar Treatment: Product Landscape
- 7.2.1 Analysis by Scar Type
- 7.2.2 Analysis by Product Type
- 7.2.3 Analysis by End User
- 8 Scar Challenges and Unmet Needs
- 8.1 Scar Type Pathway Challenges
- 8.2 Compliance and Drop-Out Analysis
- 8.3 Awareness and Prevention Gaps
- 9 Cost of Scar Treatment
- 10 Scar Treatment Market Dynamics
- 10.1 Market Drivers and Constraints
- 10.2 SWOT Analysis
- 10.3 Porter’s Five Forces Model
- 10.4 Key Demand Indicators
- 10.5 Key Price Indicators
- 10.6 Industry Events, Initiatives, and Trends
- 10.7 Value Chain Analysis
- 11 Scar Treatment Market Segmentation (218-2034) - 8 Major Markets
- 11.1 Scar Treatment Market (2018-2034) by Scar Type
- 11.1.1 Market Overview
- 11.1.2 Atrophic Scars
- 11.1.3 Hypertrophic and Keloid Scars
- 11.1.4 Contracture Scars
- 11.1.5 Stretch Marks
- 11.2 Scar Treatment Market (2018-2034) by Product
- 11.2.1 Market Overview
- 11.2.2 Topical Products
- 11.2.2.1 Creams
- 11.2.2.2 Gels
- 11.2.2.3 Silicon Sheets
- 11.2.2.4 Others
- 11.2.3 Laser Products
- 11.2.3.1 CO2 Laser
- 11.2.3.2 Pulse-dyed Laser
- 11.2.3.3 Others
- 11.2.4 Injectable
- 11.2.5 Others
- 11.3 Scar Treatment Market (2018-2034) by End User
- 11.3.1 Hospitals
- 11.3.2 Ambulatory Surgical Centers
- 11.3.3 Others
- 11.4 Scar Treatment Market (2018-2034) by Region
- 11.4.1 Market Overview
- 11.4.2 United States
- 11.4.3 EU-4 and the United Kingdom
- 11.4.3.1 Germany
- 11.4.3.2 France
- 11.4.3.3 Italy
- 11.4.3.4 Spain
- 11.4.3.5 United Kingdom
- 11.4.4 Japan
- 11.4.5 India
- 12 United States Scar Treatment Market (218-2034)
- 12.1 United States Scar Treatment Market Historical Value (2018-2024)
- 12.2 United States Scar Treatment Market Forecast Value (2025-2034)
- 12.3 United States Scar Treatment Market (2018-2034) by Scar Type
- 12.3.1 Market Overview
- 12.3.2 Atrophic Scars
- 12.3.3 Hypertrophic and Keloid Scars
- 12.3.4 Contracture Scars
- 12.3.5 Stretch Marks
- 12.4 United States Scar Treatment Market (2018-2034) by Product
- 12.4.1 Market Overview
- 12.4.2 Topical Products
- 12.4.2.1 Creams
- 12.4.2.2 Gels
- 12.4.2.3 Silicon Sheets
- 12.4.2.4 Others
- 12.4.3 Laser Products
- 12.4.3.1 CO2 Laser
- 12.4.3.2 Pulse-dyed Laser
- 12.4.3.3 Others
- 12.4.4 Injectable
- 12.4.5 Others
- 13 EU-4 and United Kingdom Scar Treatment Market (218-2034)
- 13.1 EU-4 and United Kingdom Scar Treatment Market Historical Value (2018-2024)
- 13.2 EU-4 and United Kingdom Scar Treatment Market Forecast Value (2025-2034)
- 13.3 EU-4 and United Kingdom Scar Treatment Market (2018-2034) by Scar Type
- 13.3.1 Market Overview
- 13.3.2 Atrophic Scars
- 13.3.3 Hypertrophic and Keloid Scars
- 13.3.4 Contracture Scars
- 13.3.5 Stretch Marks
- 13.4 EU-4 and United Kingdom Scar Treatment Market (2018-2034) by Product
- 13.4.1 Market Overview
- 13.4.2 Topical Products
- 13.4.2.1 Creams
- 13.4.2.2 Gels
- 13.4.2.3 Silicon Sheets
- 13.4.2.4 Others
- 13.4.3 Laser Products
- 13.4.3.1 CO2 Laser
- 13.4.3.2 Pulse-dyed Laser
- 13.4.3.3 Others
- 13.4.4 Injectable
- 13.4.5 Others
- 14 Japan Scar Treatment Market
- 14.1 Japan Scar Treatment Market Historical Value (2018-2024)
- 14.2 Japan Scar Treatment Market Forecast Value (2025-2034)
- 14.3 Japan Scar Treatment Market (2018-2034) by Scar Type
- 14.3.1 Market Overview
- 14.3.2 Atrophic Scars
- 14.3.3 Hypertrophic and Keloid Scars
- 14.3.4 Contracture Scars
- 14.3.5 Stretch Marks
- 14.4 Japan Scar Treatment Market (2018-2034) by Product
- 14.4.1 Market Overview
- 14.4.2 Topical Products
- 14.4.2.1 Creams
- 14.4.2.2 Gels
- 14.4.2.3 Silicon Sheets
- 14.4.2.4 Others
- 14.4.3 Laser Products
- 14.4.3.1 CO2 Laser
- 14.4.3.2 Pulse-dyed Laser
- 14.4.3.3 Others
- 14.4.4 Injectable
- 14.4.5 Others
- 15 India Scar Treatment Market
- 15.1 India Scar Treatment Market (2018-2034) Historical Value (2018-2024)
- 15.2 India Scar Treatment Market (2018-2034) Forecast Value (2025-2034)
- 15.3 India Scar Treatment Market (2018-2034) by Scar Type
- 15.3.1 Market Overview
- 15.3.2 Atrophic Scars
- 15.3.3 Hypertrophic and Keloid Scars
- 15.3.4 Contracture Scars
- 15.3.5 Stretch Marks
- 15.4 India Scar Treatment Market (2018-2034) by Product
- 15.4.1 Market Overview
- 15.4.2 Topical Products
- 15.4.2.1 Creams
- 15.4.2.2 Gels
- 15.4.2.3 Silicon Sheets
- 15.4.2.4 Others
- 15.4.3 Laser Products
- 15.4.3.1 CO2 Laser
- 15.4.3.2 Pulse-dyed Laser
- 15.4.3.3 Others
- 15.4.4 Injectable
- 15.4.5 Others
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 Japan PMDA
- 16.1.4 India CDSCO
- 16.1.5 Others
- 17 Patent Analysis
- 17.1 Analysis by Drug Type of Patent
- 17.2 Analysis by Publication Year
- 17.3 Analysis by Issuing Authority
- 17.4 Analysis by Patent Age
- 17.5 Analysis by CPC Analysis
- 17.6 Analysis by Patent Valuation
- 17.7 Analysis by Key Players
- 18 Grants Analysis
- 18.1 Analysis by Year
- 18.2 Analysis by Amount Awarded
- 18.3 Analysis by Issuing Authority
- 18.4 Analysis by Grant Application
- 18.5 Analysis by Funding Institute
- 18.6 Analysis by NIH Departments
- 18.7 Analysis by Recipient Organization
- 19 Clinical Trials Analysis
- 19.1 Analysis by Trial Registration Year
- 19.2 Analysis by Trial Status
- 19.3 Analysis by Trial Phase
- 19.4 Analysis by Therapeutic Area
- 19.5 Analysis by Geography
- 20 Funding and Investment Analysis
- 20.1 Analysis by Funding Instances
- 20.2 Analysis by Drug Type of Funding
- 20.3 Analysis by Funding Amount
- 20.4 Analysis by Leading Players
- 20.5 Analysis by Leading Investors
- 20.6 Analysis by Geography
- 21 Partnership and Collaborations Analysis
- 21.1 Analysis by Partnership Instances
- 21.2 Analysis by Drug Type of Partnership
- 21.3 Analysis by Leading Players
- 21.4 Analysis by Geography
- 22 Supplier Landscape
- 22.1 Alliance Pharma PLC
- 22.1.1 Financial Analysis
- 22.1.2 Product Portfolio
- 22.1.3 Demographic Reach and Achievements
- 22.1.4 Mergers and Acquisitions
- 22.1.5 Certifications
- 22.2 Perrigo Company plc
- 22.2.1 Financial Analysis
- 22.2.2 Product Portfolio
- 22.2.3 Demographic Reach and Achievements
- 22.2.4 Mergers and Acquisitions
- 22.2.5 Certifications
- 22.3 Newmedical Technology Inc.
- 22.3.1 Financial Analysis
- 22.3.2 Product Portfolio
- 22.3.3 Demographic Reach and Achievements
- 22.3.4 Mergers and Acquisitions
- 22.3.5 Certifications
- 22.4 Sonoma Pharmaceuticals, Inc.
- 22.4.1 Financial Analysis
- 22.4.2 Product Portfolio
- 22.4.3 Demographic Reach and Achievements
- 22.4.4 Mergers and Acquisitions
- 22.4.5 Certifications
- 22.5 HRA Pharma
- 22.5.1 Financial Analysis
- 22.5.2 Product Portfolio
- 22.5.3 Demographic Reach and Achievements
- 22.5.4 Mergers and Acquisitions
- 22.5.5 Certifications
- 22.6 Boston Scientific Corporation
- 22.6.1 Financial Analysis
- 22.6.2 Product Portfolio
- 22.6.3 Demographic Reach and Achievements
- 22.6.4 Mergers and Acquisitions
- 22.6.5 Certifications
- 22.7 CCA Industries, Inc.
- 22.7.1 Financial Analysis
- 22.7.2 Product Portfolio
- 22.7.3 Demographic Reach and Achievements
- 22.7.4 Mergers and Acquisitions
- 22.7.5 Certifications
- 22.8 Avita Medical,Inc.
- 22.8.1 Financial Analysis
- 22.8.2 Product Portfolio
- 22.8.3 Demographic Reach and Achievements
- 22.8.4 Mergers and Acquisitions
- 22.8.5 Certifications
- 22.9 Smith & Nephew PLC
- 22.9.1 Financial Analysis
- 22.9.2 Product Portfolio
- 22.9.3 Demographic Reach and Achievements
- 22.9.4 Mergers and Acquisitions
- 22.9.5 Certifications
- 22.10 Shanghai Fosun Pharmaceutical?Group?Co., Ltd.
- 22.10.1 Financial Analysis
- 22.10.2 Product Portfolio
- 22.10.3 Demographic Reach and Achievements
- 22.10.4 Mergers and Acquisitions
- 22.10.5 Certifications
- 22.11 Sientra, Inc.
- 22.11.1 Financial Analysis
- 22.11.2 Product Portfolio
- 22.11.3 Demographic Reach and Achievements
- 22.11.4 Mergers and Acquisitions
- 22.11.5 Certifications
- 22.12 Mölnlycke Health Care AB
- 22.12.1 Financial Analysis
- 22.12.2 Product Portfolio
- 22.12.3 Demographic Reach and Achievements
- 22.12.4 Mergers and Acquisitions
- 22.12.5 Certifications
- 22.13 Merz Pharma
- 22.13.1 Financial Analysis
- 22.13.2 Product Portfolio
- 22.13.3 Demographic Reach and Achievements
- 22.13.4 Mergers and Acquisitions
- 22.13.5 Certifications
- 22.14 POLYTECH Health & Aesthetics GmbH
- 22.14.1 Financial Analysis
- 22.14.2 Product Portfolio
- 22.14.3 Demographic Reach and Achievements
- 22.14.4 Mergers and Acquisitions
- 22.14.5 Certifications
- 22.15 CYNOSURE LUTRONIC
- 22.15.1 Financial Analysis
- 22.15.2 Product Portfolio
- 22.15.3 Demographic Reach and Achievements
- 22.15.4 Mergers and Acquisitions
- 22.15.5 Certifications
- 23 Scar Treatment Market - Distribution Model (Additional Insight)
- 23.1 Overview
- 23.2 Potential Distributors
- 23.3 Key Parameters for Distribution Partner Assessment
- 24 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 25 Company Competitiveness Analysis (Additional Insight)
- 25.1 Very Small Companies
- 25.2 Small Companies
- 25.3 Mid-Sized Companies
- 25.4 Large Companies
- 25.5 Very Large Companies
- 26 Payment Methods (Additional Insight)
- 26.1 Government Funded
- 26.2 Private Insurance
- 26.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.